Logo image
Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians
Journal article   Open access   Peer reviewed

Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians

Michael A. Lane, Jonas Marschall, Susan E. Beekmann, Philip M. Polgreen, Ritu Banerjee, Adam L. Hersh and Hilary M. Babcock
Infection control and hospital epidemiology, v 35(7), pp 839-844
01 Jul 2014
PMID: 24915212
url
https://doi.org/10.1086/676859View
Published, Version of Record (VoR)Open Access (License Unspecified) Open

Abstract

Infectious Diseases Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology
OBJECTIVE. To identify current outpatient parenteral antibiotic therapy practice patterns and complications. METHODS. We administered an 11-question survey to adult infectious disease physicians participating in the Emerging Infections Network (EIN), a Centers for Disease Control and Prevention-sponsored sentinel event surveillance network in North America. The survey was distributed electronically or via facsimile in November and December 2012. Respondent demographic characteristics were obtained from EIN enrollment data. RESULTS. Overall, 555 (44.6%) of EIN members responded to the survey, with 450 (81%) indicating that they treated 1 or more patients with outpatient parenteral antimicrobial therapy (OPAT) during an average month. Infectious diseases consultation was reported to be required for a patient to be discharged with OPAT by 99 respondents (22%). Inpatient (282 [63%] of 449) and outpatient (232 [52%] of 449) infectious diseases physicians were frequently identified as being responsible for monitoring laboratory results. Only 26% (118 of 448) had dedicated OPAT teams at their clinical site. Few infectious diseases physicians have systems to track errors, adverse events, or "near misses" associated with OPAT (97 [22%] of 449). OPAT-associated complications were perceived to be rare. Among respondents, 80% reported line occlusion or clotting as the most common complication (occurring in 6% of patients or more), followed by nephrotoxicity and rash (each reported by 61%). Weekly laboratory monitoring of patients who received vancomycin was reported by 77% of respondents (343 of 445), whereas 19% of respondents (84 of 445) reported twice weekly laboratory monitoring for these patients. CONCLUSIONS. Although use of OPAT is common, there is significant variation in practice patterns. More uniform OPAT practices may enhance patient safety.

Metrics

5 Record Views
54 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Infectious Diseases
Public, Environmental & Occupational Health
Logo image